4//SEC Filing
Anderson Douglas Brian 4
Accession 0001104659-22-063412
CIK 0001821318other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:36 PM ET
Size
12.3 KB
Accession
0001104659-22-063412
Insider Transaction Report
Form 4
Anderson Douglas Brian
DirectorChief Financial Officer
Transactions
- Conversion
Class A Common Stock
2022-05-19+11,781→ 11,781 total - Other
Class A Common Stock
2022-05-19−11,781→ 0 total - Conversion
Class B Common Stock
2022-05-19−11,781→ 0 total→ Class A Common Stock (11,781 underlying) - Other
Warrant
2022-05-19−25,000→ 0 total→ Class A Common Stock (25,000 underlying)
Footnotes (5)
- [F1]As described in the issuer's registration statement on Form S-1 (File No. 333-248093) (the "Registration Statement") under the heading "Description of Securities," the shares of Class B common stock, par value $0.0001 per share ("Class B Stock"), automatically convert into shares of Class A common stock, par value $0.0001 per share ("Class A Stock"), at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and certain anti-dilution rights and has no expiration date.
- [F2](Continued from Footnote 1) On May 19, 2022, the issuer consummated its initial business combination (the "Business Combination") with Comera Life Sciences Holdings, Inc.. ("Holdco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Stock converted into Class A Stock.
- [F3]In connection with the Business Combination, the reporting person exchanged its Class A Shares for 11,781 fully paid and non-assessable shares of common stock, par value U.S. $0.0001 per share, of Holdco Common Stock.
- [F4]In connection with the Business Combination, the reporting person exchanged each of its warrants to purchase shares of Class A Stock on a one for one basis for an aggregate of 25,000 warrants to purchase shares of Holdco Common Stock at a purchase price of $11.50 per share.
- [F5]The warrants were not exercisable until 30 days after the issuer's initial business combination and would have expired five years from the consummation of the issuer's initial business combination.
Documents
Issuer
OTR Acquisition Corp.
CIK 0001821318
Entity typeother
Related Parties
1- filerCIK 0001830322
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:36 PM ET
- Size
- 12.3 KB